TrialBritish journal of clinical pharmacology2009

Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects.

Xia Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.